英文别名: |
(2r-cis)-4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1h)-pyrimidinone;3TC;3'-THIA-2',3'-DIDEOXYCYTIDINE;4-AMINO-1-((2R,5S)-2-HYDROXYMETHYL-[1,3]OXATHIOLAN-5-YL)-1H-PYRIMIDIN-2-ONE;(-)-BCH-189;(-)-BETA-L-2',3'-DIDEOXY-3'-THIACYTIDINE;(-)-B-L-2',3'-DIDEOXY-3'-THIACYTIDINE;(-)-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cystosine;(-)-2¢;(-)NGPB-21;(2R-cis)-4-amino-1-;,3¢;2(1H)-Pyrimidinone,4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-,(2R-cis)-;3'-thia-2',3'-dideoxcytidine;-deoxy-3¢;Epivir;GR109714X;-thia-2¢;LAMIVUDINE;拉米夫定;[
""
];2'-Deoxy-3'-thiacytidine;(2R-cis)-4-Amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone;Lamivudine;2′,3′-Dideoxy-3′-thiacytidine;Epivir-HBV;4-Amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one;Zefix;Zeffix;LaMivudine Resolution Mixture A;Heptovir;Heptivir;Hepitec;cent;3&L-SddC;2',3'-Dideoxy-3'-thiacytidine;(-)-1-[(2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine;Lamivudine ( 3TC,Epivir-HBV,Epivir®,Heptovir®, Zeffix®);2(1H)-Pyrimidinone, 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]- |
中文别名: |
(2R-顺式)-4-氨基-1-(2-羟甲基-1,3-氧硫杂环戊-5-基)-1H-嘧啶-2-酮;拉米呋啶;拉夫米定;拉米呋定;拉米夫啶;(2R-顺式)-4-氨基-1-[2-(羟基甲基)-1,3-嘿噻烷-5-基]-2(1H)-嘧啶酮;拉米夫定;拉米夫定溶液混合物A;拉美呋定杂质A;拉美呋定;托吡酯;马来酸依那普利;拉米呋啶中间体;拉米呋啶 标准品;拉米夫定系统适用性2 EP标准品;拉米夫定系统适用性1 EP标准品;拉米夫定Lamivudine;拉米夫定-13C-D2;拉米夫定 标准品;拉米夫定 USP标准品;拉米夫定 EP标准品;拉咪夫定;氨基封端聚二甲基硅氧烷;Lamivudine 拉米夫定;2,2,6,6-四甲基-1-(1-苯基乙氧基) |